Background: The use of abacavir has been linked to cardiovascular disease. We have demonstrated (using a flow chamber system in vitro) that cyclic purine analogues (abacavir and didanosine) induce leukocyte-endothelial cell interactions through Mac-1/ICAM-1 interaction, and that this effect is not produced by pyrimidine analogues (lamivudine, zidovudine, emtricitabine) or the acyclic nucleotide tenofovir. However, the molecular mechanism underlying these interactions remains elusive. Given the chemical structure of abacavir, we have explored whether its proinflammatory effects are a result of the interference of its structure with the purine signalling pathway. Methodology: Human umbilical vein endothelial cells (HUVEC) and polymorphonuclear leukocytes (PMN) were treated with abacavir (0.5-15 μmol/L) to determine: 1) intracellular ATP levels by a luciferase bioluminescence assay; and 2) expression of CD73 (the enzyme responsible for ATP degradation) by western blotting. To analyse the role of ATP and its receptors in the leukocyte accumulation induced by abacavir, HUVEC and PMN were pre-treated with antagonists of P2X7 ATP receptors [oxATP (600 μmol/L) or BGG (5 μmol/L)] prior to abacavir (10 μmol/L, 4h) administration and leukocyte-endothelium interactions were then measured using a flow chamber system. Data are expressed as mean}SEM. Statistical analysis was performed with one-way ANOVA and a Newman-Keuls post-hoc test, with significance set at **p<0.01 (vs. control), n≥3. Results: Clinical concentrations of abacavir (0.5-15 μmol/L, 4h) produced an increase in intracellular ATP levels on HUVEC (abacavir 10 μmol/L: 197.6}22.4** vs. 100% control) and PMN (abacavir 10 μmol/L: 158.1}15.4** vs. 100% control) and a decrease in CD73 expression on HUVEC (abacavir 10 μmol/L: 52.2}10.2** vs. 100% control) and PMN (abacavir 10 μmol/L: 18.7}14.7** vs. 100% control). Abacavir-induced leukocyte-endothelial cell interactions were absent following pre-treatment with P2X7 receptor antagonists. Conclusions: Our results suggest a structure-activity relationship in the effects of abacavir on leukocyte accumulation through the interaction of ATP with its P2X7 receptors. This proinflammatory mechanism may be especially relevant for understanding the vascular damage observed in abacavir-treated patients.